B Majchrzak
Overview
Explore the profile of B Majchrzak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
348
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Klosinska D, Ciszek B, Majchrzak B, Badurek I, Ratajska A
Folia Morphol (Warsz)
. 2019 Jul;
79(2):255-264.
PMID: 31257564
Background: Research on the development and topography of mouse coronary arteries has been conducted for many years. Patterns of the course of these vessels have been described in various mouse...
2.
Mayer I, Verma A, Grumbach I, Uddin S, Lekmine F, Ravandi F, et al.
J Biol Chem
. 2001 May;
276(30):28570-7.
PMID: 11353767
The mechanisms by which interferon-alpha (IFN-alpha) mediates its anti-leukemic effects in chronic myelogenous leukemia (CML) cells are not known. We determined whether p38 MAPK is activated by IFN-alpha in BCR-ABL-expressing...
3.
Wong M, Uddin S, Majchrzak B, Huynh T, Proudfoot A, Platanias L, et al.
J Biol Chem
. 2001 Mar;
276(14):11427-31.
PMID: 11278738
The chemokine RANTES (regulated on activation normal T cell expressed and secreted) and its cognate receptor CC chemokine receptor 5 (CCR5) have been implicated in regulating immune cell function. Previously...
4.
Grumbach I, Mayer I, Uddin S, Lekmine F, Majchrzak B, Yamauchi H, et al.
Br J Haematol
. 2001 Feb;
112(2):327-36.
PMID: 11167825
Interferon alpha (IFNalpha) has significant clinical activity in the treatment of patients with chronic myelogenous leukaemia (CML), but the mechanisms of its selective efficacy in the treatment of the disease...
5.
Uddin S, Lekmine F, Sharma N, Majchrzak B, Mayer I, Young P, et al.
J Biol Chem
. 2000 Jul;
275(36):27634-40.
PMID: 10878008
The p38 mitogen-activated protein (MAP) kinase is activated during engagement of the type I interferon (IFN) receptor and mediates signals essential for IFNalpha-dependent transcriptional activation via interferon-stimulated response elements without...
6.
Wagner T, Rani M, Vogel D, Colamonici O, Ransohoff R, Majchrzak B, et al.
J Biol Chem
. 2000 May;
275(31):23981-5.
PMID: 10825167
A human cell line (U5A) lacking the type I interferon (IFN) receptor chain 2 (IFNAR2c) was used to determine the role of the IFNAR2c cytoplasmic domain in regulating IFN-dependent STAT...
7.
Uddin S, Majchrzak B, Wang P, Modi S, Khan M, Fish E, et al.
Biochem Biophys Res Commun
. 2000 Mar;
270(1):158-62.
PMID: 10733921
Several signaling pathways are activated by interferon alpha (IFNalpha) in hematopoietic cells, including the Jak-Stat and the insulin receptor substrate (IRS) pathways. It has been previously shown that IFNalpha activates...
8.
AlSayed Y, Uddin S, Ahmad S, Majchrzak B, Druker B, Fish E, et al.
J Immunol
. 2000 Feb;
164(4):1800-6.
PMID: 10657627
IFN-gamma transduces signals by activating the IFN-gamma receptor-associated Jak-1 and Jak-2 kinases and by inducing tyrosine phosphorylation and activation of the Stat-1 transcriptional activator. We report that IFN-gamma activates a...
9.
Uddin S, Majchrzak B, Woodson J, Arunkumar P, AlSayed Y, Pine R, et al.
J Biol Chem
. 1999 Oct;
274(42):30127-31.
PMID: 10514501
The p38 mitogen-activated protein (Map) kinase plays a critical role in the generation of signals in response to stress stimuli, but its role in interferon (IFN) signaling and its potential...
10.
Grumbach I, Fish E, Uddin S, Majchrzak B, Colamonici O, Figulla H, et al.
J Interferon Cytokine Res
. 1999 Aug;
19(7):797-801.
PMID: 10454351
We determined whether selective activation of components of the Jak-Stat pathway by different type I interferons (IFN) occurs in human myocardial fibroblasts that exhibit much higher sensitivity to the antiviral...